Alessandro Levis
About
Alessandro Levis is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology.
According to data from OpenAlex, Alessandro Levis has authored 100 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pathology and Forensic Medicine, 35 papers in Genetics and 33 papers in Hematology. Recurrent topics in Alessandro Levis's work include Lymphoma Diagnosis and Treatment (57 papers), Chronic Lymphocytic Leukemia Research (30 papers) and Lung Cancer Treatments and Mutations (22 papers). Alessandro Levis is often cited by papers focused on Lymphoma Diagnosis and Treatment (57 papers), Chronic Lymphocytic Leukemia Research (30 papers) and Lung Cancer Treatments and Mutations (22 papers). Alessandro Levis collaborates with scholars based in Italy, United States and Switzerland. Alessandro Levis's co-authors include Umberto Vitolo, Andrea Gallamini, Luigi Rigacci, Francesco Merli, Emilio Iannitto, Caterina Stelitano, Stefano Luminari, Alberto Biggi, Caterina Patti and Simonetta Viviani and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
In The Last Decade
Alessandro Levis
94 papers receiving 3.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Alessandro Levis Italy | 32 | 2.1k | 1.3k | 1.1k | 819 | 751 | 100 | 3.8k | ||
| Réda Bouabdallah France | 28 | 1.9k 0.9× | 2.0k 1.6× | 1.5k 1.3× | 600 0.7× | 347 0.5× | 101 | 4.0k | ||
| J L Harousseau France | 22 | 1.8k 0.8× | 1.8k 1.4× | 1.1k 1.0× | 590 0.7× | 291 0.4× | 36 | 3.3k | ||
| Frederick Hagemeister United States | 27 | 2.3k 1.1× | 1.7k 1.3× | 389 0.4× | 470 0.6× | 603 0.8× | 69 | 3.3k | ||
| Tarun Kewalramani United States | 20 | 1.4k 0.7× | 1.6k 1.2× | 471 0.4× | 545 0.7× | 758 1.0× | 48 | 2.9k | ||
| Bertram Glaß Germany | 26 | 2.4k 1.1× | 2.2k 1.7× | 922 0.8× | 944 1.2× | 283 0.4× | 102 | 4.1k | ||
| F Reyes France | 30 | 3.4k 1.6× | 2.3k 1.8× | 789 0.7× | 909 1.1× | 442 0.6× | 64 | 4.9k | ||
| Lode J. Swinnen United States | 32 | 1.5k 0.7× | 2.4k 1.9× | 931 0.8× | 448 0.5× | 397 0.5× | 110 | 4.3k | ||
| Marine Diviné France | 39 | 2.8k 1.3× | 2.2k 1.7× | 1.8k 1.6× | 830 1.0× | 482 0.6× | 112 | 5.1k | ||
| Aspasia Stamatoullas France | 34 | 1.7k 0.8× | 1.3k 1.0× | 1.4k 1.2× | 449 0.5× | 289 0.4× | 126 | 3.6k | ||
| William S. Velasquez United States | 29 | 2.5k 1.2× | 1.4k 1.1× | 459 0.4× | 638 0.8× | 597 0.8× | 58 | 3.5k |
Countries citing papers authored by Alessandro Levis
Since
Specialization
Citations
This map shows the geographic impact of Alessandro Levis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Levis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Levis more than expected).
Fields of papers citing papers by Alessandro Levis
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Alessandro Levis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Levis. The network helps show where Alessandro Levis may publish in the future.
Co-authorship network of co-authors of Alessandro Levis
This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Levis. A scholar is included among the top collaborators of Alessandro Levis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Levis. Alessandro Levis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Zallio, Francesco, Stefania Tamiazzo, Chiara Monagheddu, et al.. (2016). Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL ). British Journal of Haematology. 172(6). 879–888.
2.
Rigacci, Luigi, Benedetta Puccini, Pier Luigi Zinzani, et al.. (2015). The prognostic value of positron emission tomography performed after two courses (INTERIM‐PET ) of standard therapy on treatment outcome in early stage H odgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL). American Journal of Hematology. 90(6). 499–503.
3.
Intermesoli, Tamara, Alessandro Rambaldi, Giuseppe Rossi, et al.. (2013). High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program. Haematologica. 98(11). 1718–1725.
4.
Fianchi, Luana, Marianna Criscuolo, Monia Lunghi, et al.. (2012). Outcome of therapy-related myeloid neoplasms treated with azacitidine. Journal of Hematology & Oncology. 5(1). 44–44.
5.
Filippi, Andrea Riccardo, Angela Botticella, Marilena Bellò, et al.. (2012). Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy. Leukemia & lymphoma. 54(6). 1183–1187.
6.
Galimberti, Sara, Francesca Guerrini, Flavia Salvi, et al.. (2012). Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study. Journal of Hematology & Oncology. 5(1). 53–53.
7.
Gobbi, Paolo G., Andrés J.M. Ferreri, Maurilio Ponzoni, & Alessandro Levis. (2012). Hodgkin lymphoma. Critical Reviews in Oncology/Hematology. 85(2). 216–237.
8.
Cattaneo, Chiara, Suzanne M. de la Monte, Alessandra Algarotti, et al.. (2011). A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study). Journal of Antimicrobial Chemotherapy. 66(9). 2140–2145.
9.
Viviani, Simonetta, Pier Luigi Zinzani, Alessandro Rambaldi, et al.. (2011). ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned. New England Journal of Medicine. 365(3). 203–212.
10.
Castagna, Luca, Stéfania Bramanti, Alessandro Levis, et al.. (2009). Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell support. Annals of Oncology. 21(7). 1482–1485.
11.
Oliva, Esther N., Cristina Clissa, Valeria Santini, et al.. (2008). Quality of Life Assessment in Patients Affected by Myelodysplastic Syndrome. Blood. 112(11). 2363–2363.
12.
Gallamini, Andrea, Martin Hutchings, Luigi Rigacci, et al.. (2007). Early Interim 2-[ 18 F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study. Journal of Clinical Oncology. 25(24). 3746–3752.
13.
Gobbi, Paolo G., Chiara Broglia, Alessandro Levis, et al.. (2006). MOPPEBVCAD Chemotherapy with Limited and Conditioned Radiotherapy in Advanced Hodgkin's Lymphoma: 10-Year Results, Late Toxicity, and Second Tumors. Clinical Cancer Research. 12(2). 529–535.
14.
Gallamini, Andrea, Francesco Zaja, Livio Gargantini, et al.. (2005). CHOP Chemotherapy Plus Campath-1H (CHOP-C) as First Line Treatment in Patients with Peripheral T-Cell Lymphoma (PTCL).. Blood. 106(11). 3345–3345.
15.
Levis, Alessandro, et al.. (2002). Treatment of Elderly Hodgkin's Lymphoma Patients. The Experience of the Italian Lymphoma Intergroup. Tumori Journal. 88(1_suppl1). S29–S31.
16.
Aglietta, Massimo, Filippo Montemurro, Franca Fagioli, et al.. (2000). Short term treatment withEscheria coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease. Cancer. 88(2). 454–460.
17.
Vitolo, Umberto, Anna Marina Liberati, Roberto Freilone, et al.. (1997). Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma.. Journal of Clinical Oncology. 15(2). 491–498.
18.
Ciccone, Giovannino, Dario Mirabelli, Alessandro Levis, et al.. (1993). Myeloid leukemias and myelodysplastic syndromes: chemical exposure, histologic subtype and cytogenetics in a case-control study. Cancer Genetics and Cytogenetics. 68(2). 135–139.
19.
Vitolo, Umberto, Lorella Orsucci, M Bertini, et al.. (1991). Mitoxantrone, etoposide, cisplatin and dexamethasone (MEPD) as salvage chemotherapy in resistant non-Hodgkin's lymphoma.. PubMed. 76(1). 43–6.
20.
Levis, Alessandro, et al.. (1986). Peripheral erythroid precursor and prognosis in chronic granulocytic leukemia. Cancer. 58(2). 229–233.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Réda Bouabdallah Breakdown of academic impact, for papers by J L Harousseau Breakdown of academic impact, for papers by Frederick Hagemeister Breakdown of academic impact, for papers by Tarun Kewalramani Breakdown of academic impact, for papers by Bertram Glaß Breakdown of academic impact, for papers by F Reyes Breakdown of academic impact, for papers by Lode J. Swinnen Breakdown of academic impact, for papers by Marine Diviné Breakdown of academic impact, for papers by Aspasia Stamatoullas Breakdown of academic impact, for papers by William S. Velasquez